Biomaterial Database

Effects of iron, riboflavin and iodide deficiencies on hepatic drug-metabolizing enzyme systems. 1970

C S Catz, and M R Juchau, and S J Yaffe

UI	MeSH Term	Description	Entries
D007037	Hypothyroidism	A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA. It may be primary or secondary due to other pituitary disease, or hypothalamic dysfunction.	Central Hypothyroidism,Primary Hypothyroidism,Secondary Hypothyroidism,TSH Deficiency,Thyroid-Stimulating Hormone Deficiency,Central Hypothyroidisms,Deficiency, TSH,Deficiency, Thyroid-Stimulating Hormone,Hormone Deficiency, Thyroid-Stimulating,Hypothyroidism, Central,Hypothyroidism, Primary,Hypothyroidism, Secondary,Hypothyroidisms,Primary Hypothyroidisms,Secondary Hypothyroidisms,TSH Deficiencies,Thyroid Stimulating Hormone Deficiency,Thyroid-Stimulating Hormone Deficiencies
D007454	Iodides	Inorganic binary compounds of iodine or the I- ion.	Iodide
D007501	Iron	A metallic element with atomic symbol Fe, atomic number 26, and atomic weight 55.85. It is an essential constituent of HEMOGLOBINS; CYTOCHROMES; and IRON-BINDING PROTEINS. It plays a role in cellular redox reactions and in the transport of OXYGEN.	Iron-56,Iron 56
D008862	Microsomes, Liver	Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough.	Liver Microsomes,Liver Microsome,Microsome, Liver
D009596	Nitrophenols	PHENOLS carrying nitro group substituents.	Nitrophenol
D011441	Propylthiouracil	A thiourea antithyroid agent. Propythiouracil inhibits the synthesis of thyroxine and inhibits the peripheral conversion of throxine to tri-iodothyronine. It is used in the treatment of hyperthyroidism. (From Martindale, The Extra Pharmacopeoia, 30th ed, p534)	6-Propyl-2-Thiouracil,6 Propyl 2 Thiouracil
D003580	Cytochromes	Hemeproteins whose characteristic mode of action involves transfer of reducing equivalents which are associated with a reversible change in oxidation state of the prosthetic group. Formally, this redox change involves a single-electron, reversible equilibrium between the Fe(II) and Fe(III) states of the central iron atom (From Enzyme Nomenclature, 1992, p539). The various cytochrome subclasses are organized by the type of HEME and by the wavelength range of their reduced alpha-absorption bands.	Cytochrome
D003677	Deficiency Diseases	A condition produced by dietary or metabolic deficiency. The term includes all diseases caused by an insufficient supply of essential nutrients, i.e., protein (or amino acids), vitamins, and minerals. It also includes an inadequacy of calories. (From Dorland, 27th ed; Stedman, 25th ed)	Deficiency Disease,Disease, Deficiency,Diseases, Deficiency
D006591	Hexobarbital	A barbiturate that is effective as a hypnotic and sedative.	Evipan,Hexenal,Hexobarbitone,Sodium Hexobarbital,Hexobarbital, Sodium
D000367	Age Factors	Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time.	Age Reporting,Age Factor,Factor, Age,Factors, Age

Related Publications

C S Catz, and M R Juchau, and S J Yaffe

Selective effects of methaqualone on drug metabolizing enzyme systems.

January 1980, Proceedings of the Western Pharmacology Society,

C S Catz, and M R Juchau, and S J Yaffe

Effects of human placental extract on hepatic drug metabolizing enzyme.

January 1995, Rivista europea per le scienze mediche e farmacologiche = European review for medical and pharmacological sciences = Revue europeenne pour les sciences medicales et pharmacologiques,

C S Catz, and M R Juchau, and S J Yaffe

Interactions of spironolactone with hepatic microsomal drug-metabolizing enzyme systems.

August 1971, Biochemical pharmacology,

C S Catz, and M R Juchau, and S J Yaffe

The effects of 1-alkylimidazoles on hepatic drug-metabolizing enzyme activity.

April 1974, Xenobiotica; the fate of foreign compounds in biological systems,

C S Catz, and M R Juchau, and S J Yaffe

Two-substrate kinetics of drug-metabolizing enzyme systems of hepatic microsomes.

May 1970, Molecular pharmacology,

C S Catz, and M R Juchau, and S J Yaffe

Effects of D-003 on hepatic drug-metabolizing enzyme activities in rats.

January 2004, Journal of medicinal food,